Prime Medicine (PRME) Other Non Operating Income (2021 - 2026)
Prime Medicine (PRME) posted Other Non Operating Income of $51000.0 for Q1 2026, up 4.08% on a QoQ basis from $49000.0 in Q4 2025, and up 37.84% year-over-year from $37000.0 in Q1 2025.
Prime Medicine (PRME) Other Non Operating Income (2021 - 2026) Analysis & Trends
Prime Medicine's Other Non Operating Income history runs 6 years deep, the most recent figure standing at $51000.0 for Q1 2026.
- Quarterly Other Non Operating Income rose 37.84% year-over-year to $51000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $162000.0 (up 350.0% YoY) and the FY2025 annual result came in at $148000.0, up 260.98% from the prior year.
- Other Non Operating Income was $51000.0 for Q1 2026 at Prime Medicine, up from $49000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $2.1 million in Q1 2023 and bottomed at -$83000.0 in Q3 2024.
- A 5-year average of $265294.1 and a median of $43000.0 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income soared 72900.0% — and 2024, when it slumped 293.02%.
- Prime Medicine's Other Non Operating Income stood at $926000.0 in 2022, then slumped by 84.02% to $148000.0 in 2023, then tumbled by 70.95% to $43000.0 in 2024, then rose by 13.95% to $49000.0 in 2025, then grew by 4.08% to $51000.0 in 2026.
- Business Quant data shows PRME's Other Non Operating Income at $51000.0 in Q1 2026, $49000.0 in Q4 2025, and $44000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prime Medicine | 525.98 Mn | 525.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51,000.00 |
| Dec 31, 2025 | 49,000.00 |
| Sep 30, 2025 | 44,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Sep 30, 2024 | -83,000.00 |
| Jun 30, 2024 | 39,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Dec 31, 2023 | 148,000.00 |
| Sep 30, 2023 | 43,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Mar 31, 2023 | 2.14 Mn |
| Dec 31, 2022 | 926,000.00 |
| Sep 30, 2022 | 728,000.00 |
| Jun 30, 2022 | 238,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Sep 30, 2021 | -1,000.00 |